Center for Innovation & Precision Dentistry Presents Second Annual Symposium
The symposium featured presentations and research posters by CiPD faculty and trainees in the Center’s NIDCR T90/R90 Postdoctoral Training Program as well as invited speakers.
PCI Attends Tech Connect World Innovation Conference 2023
From June 19-20, PCI attended 2023 Tech Connect World Innovation Conference and Expo, an annual event that brings together the creators of breakthrough technologies with corporations.
PCI Attends 2023 BIO International Convention
Qishui (Tracy) Chen, Assistant Director of Licensing, Physical Sciences, and Engineering shared and discussed a wide range of available drug delivery technologies come out of Penn.
Penn Engineering’s Nader Engheta Receives the Benjamin Franklin Medal for his work on metamaterials
Engheta was granted this prestigious award, which is one of the world’s oldest science and technology awards, for his transformative innovations in engineering novel metamaterials.
New Approaches to CAR-T Therapy
The FDA first approved of chimeric antigen receptor (CAR) T cell therapy in 2017, and Penn Medicine has since been dedicated to finding further applications to the treatment.
Penn Dental Medicine and Penn Engineering Faculty Invent Nanorobotic system That Offers new options for targeting fungal infections
This research team has developed a new way to accurately target and quickly destroy fungal cells in the mouth by using nanorobots guided by magnets.
Penn Dental Medicine Researchers Develop Plant-based, oral method of insulin delivery that regulates blood sugar levels similar to natural insulin
Henry Daniell and his team of researchers developed a new plant-based, oral method of insulin delivery that regulates blood sugar levels similar to natural insulin.
Former Penn Engineering Faculty Develop Tau Scientific Instruments
Fang-Yen and Fouad co-founded the startup company Tau Scientific Instruments and have licensed the Penn technology.
Future mRNA Vaccine Applications Highlighted
The New York Post recently published an article discussing future applications of mRNA, including vaccinations against tuberculosis, malaria, high cholesterol, HIV, and more.
4D Molecular Therapeutics (4DMT) Acquires Rights to Penn Medicine Invented Technology from Aevitas Therapeutics
Penn spinout Aevitas Therapeutics recently executed an asset purchase agreement with California-based biotechnology company 4D Molecular Therapeutics (4DMT).